Back

MicroRNA signatures in diabetes and myocardial infarction: in silico prediction and bench-to-bedside analysis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Biomarkers and molecular predictors in cardiovascular disease: from risk assessment to clinical application Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Ms Sara Ahmadova

Warsaw (Poland)

7 More presentations in this session

Presentation thumbnail
Kynurenine is a prognostic biomarker in pulmonary infections with association to cardiac dysfunction
Doctor A. Puetz (Aachen, DE)
Abstract Slides Video
Presentation thumbnail
Large-scale protein-disease risk association analysis in the UK Biobank
Assistant Professor S. Chlamydas (Frankfurt am Main, DE)
Abstract Slides Video
Presentation thumbnail
Examining the predictive value of plasma lysozyme for future all-cause mortality
Doctor S. Fathieh (London, GB)
Abstract Slides Video
Presentation thumbnail
Low cellular fibronectin levels are associated with bleeding in patients with atrial fibrillation: a long-term observational study
Miss K. Gladys (Cracow, PL)
Abstract Slides Video
Presentation thumbnail
Integrated Impact of hs-CRP, LDL-C and Lp(a) on Platelet Reactivity in Coronary Heart Disease Patients Receiving Dual Antiplatelet Therapy
Ms J. Li (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Biomarkers and molecular predictors in cardiovascular disease: from risk assessment to clinical application

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Circulating MicroRNA profile in coronary artery disease
thumbnail
Congress Presentation
Circulating microRNA signatures are associated with epicardial coronary dysfunction in patients underwent invasive physiological evaluation: The ANFIBIO Study
thumbnail
Congress Presentation
Methylome of circulating cell free DNA as a novel biomarker tool: from acute coronary syndrome to broader risk stratification of cardiovascular disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources